All rights reserved 2020 © InSymbiosis
Outsource drug development activities to a network of world class audited CRO’s, CMO’s and laboratories (late discovery to Phase III clinical).
Benefit from a unique financial structure that provides the CRO prices at directly discounted rates.
Uniquely structured investment deals including both cash for equity and project/asset specific investments.
Investment in assets staged from late discovery to Phase II clinical.
Rapid due diligence process.
Access to a network of drug development experts and specialists.
Flexibility to engage an expert for 1 hour, 1 day or for an entire program.
Possibility of combining access to our experts with CRO Optimizer or Investment Fund deals.